Alveus Therapeutics

Current Valuation
$123.0M
As of May 20, 2025
Total Funding Raised
$42.9M
Last Round
Early Stage VC

$37.9M

Last Funding
May 2025

Funding date

Capital Efficiency
2.87x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Alveus Therapeutics is currently valued at $123.0M as of May 20, 2025. The company has raised a total of $42.9M in funding.

Capital Efficiency

With a capital efficiency ratio of 2.87x, Alveus Therapeutics has achieved a valuation that is 2.87 times the total capital raised.

Track Alveus Therapeutics Valuation Updates

Get notified when Alveus Therapeutics raises new funding or valuation changes

Explore More Data
Detailed analysis for Alveus Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Alveus Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Alveus Therapeutics Worth in 2026?

Alveus Therapeutics is a leading private company in the technology sector. Track Alveus Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Alveus Therapeutics Valuation is Determined

Private company valuations like Alveus Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.